Find out more about the worldwide leading regeneration company and its gold standard products – Geistlich Bio-Oss® and Geistlich Bio-Gide®.

The No. 1 biomaterials company for regeneration experts.1

Success in a nutshell

Over 25 million patients treated worldwide5

Every 14 seconds a Geistlich product is used5

Premium Swiss quality

Strictly monitored manufacturing process

Only carefully selected raw materials are used

Highest safety standards and excellent biocompatibility

Talk to our experts!

Geistlich guarantees consistent, high-quality products delivered on time. Our skilled sales team is always ready to support you, anticipating your needs and providing solutions before you even have to ask. 

Geistlich was founded in Zurich-Riesbach in 1851.
The headquarters is located in Wolhusen, Switzerland.
Geistlich employs over 800 people.
1986: Introduction of Geistlich Bio-Oss®, the world’s leading bone substitute material.
1996: Introduction of Geistlich Bio-Gide®, the gold standard collagen membrane.
Today: No. 1 in bone regeneration,
represented in over 90 countries.
  1. iDATA Global Market Report Suite for Dental GL Bone Graft Substitutes and Other Biomaterials, June 2024
  2. Search conducted on 05.05.2025 in the internal library. Reference list available upon request.
  3. iData Research Inc., US Dental Bone Graft Substitutes and other Biomaterials Market, 2021.
  4. iData Research Inc., European Dental Bone Graft Substitutes and other Biomaterials Market, 2021.
  5. Data on file.
  6. Jung RE, et al., Clin Oral Implants Res. 2021 Dec;32(12):1455-1465. (clinical study)
  7. Benic GI, et al., J Clin Periodontol. 2017 Mar;44(3):315-325. (clinical study)
  8. Chappuis V, et al., J Dent Res. 2018 Mar;97(3):266-274. (clinical study)
  9. Perelman-Karmon M, et al., Int J Periodontics Restorative Dent. 2012 Aug;32(4):459-65. (clinical study)
  10. Tal H, et al., Clin Oral Implants Res 2008; 19 (3), 295-302. (clinical study)
  11. Knöfler W, et al., Int J Implant Dent. 2016 Dec;2(1):25. (clinical study)
  12. Rothamel D, et al., Clin Oral Implants Res 2005; 16 (3), 369-78. (pre-clinical study)